On March 15, 2017, David M. Cordani, President and Chief Executive Officer of Cigna Corporation (“Cigna” or the “Company”), adopted a stock trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Under Rule 10b5-1, officers, directors and other individuals who are not in possession of material non-public information may adopt a pre-arranged plan or contract for transactions in company securities under specified conditions and at specified times. Using these 10b5-1 plans, individuals can diversify their investment portfolios for financial planning purposes, plan for charitable giving, spread stock trades over an extended period of time to reduce market impact and avoid concerns about transactions occurring at a time when they might possess material non-public information. In accordance with Rule 10b5-1, Mr. Cordani will not have subsequent discretion over the transactions under his plan.

Mr. Cordani’s plan provides for transactions to occur during specified periods between May 2017 and March 2018. The plan provides for the exercise of up to 190,180 options for shares of Cigna common stock, the sale of a portion of the shares acquired from the option exercise (including the amount required to pay the exercise price, taxes and applicable fees) and the sale of shares he may receive to Cigna’s strategic performance share program following the completion of the 2015–2017 performance period. Transactions under Mr. Cordani’s plan may occur on the open market at prevailing market prices or subject to minimum price thresholds specified in the plan.

Mr. Cordani continues to be subject to the Company’s executive stock ownership guidelines, under which he is required to hold Cigna stock and stock equivalents with a value of at least six-times his base salary. Mr. Cordani does not expect the plan to materially change his ownership position.

Transactions under Mr. Cordani’s plan will be reported to the Securities and Exchange Commission in accordance with applicable securities laws, rules and regulations. The Company does not undertake to report 10b5-1 plans that may be adopted by any officers or directors in the future, or to report any modification or termination of any trading plan, whether or not the plan was publicly announced, except to the extent required by law.

About Cigna Corporation (NYSE:CI)

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate. The Global Health Care segment aggregates the commercial and Government operating segments. The Global Supplemental Benefits segment offers supplemental health, life and accident insurance products primarily in Asia, Europe and the United States. The Company’s Global Supplemental Benefits segment offers supplemental health, life and accident insurance products primarily in Asia, Europe and the United States. Its products are offered through employers and other groups, such as Governmental and non-Governmental organizations, unions and associations. Cigna also offers commercial health and dental insurance, and Medicare and Medicaid products and health.

Cigna Corporation (NYSE:CI) Recent Trading Information

Cigna Corporation (NYSE:CI) closed its last trading session down -3.36 at 145.82 with 870,230 shares trading hands.